MEDIA ADVISORY: CanniMed Therapeutics Inc. & Up Cannabis Inc. (Newstrike Resources Ltd. – TSX-V:HIP) Announce Webcast & Con...
November 20 2017 - 7:00AM
Business Wire
CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed”) and
Newstrike Resources Ltd. (TSX-V:HIP) (“Newstrike”) will be hosting
a conference call and webcast with presentation to discuss the
acquisition announced on Friday, November 17, 2017.
This press release features multimedia. View
the full release here:
http://www.businesswire.com/news/home/20171120005479/en/
Transaction Highlights
- Combining the leading medical brand
and a high profile recreational brand to create a premier global
cannabis company
- Well positioned to offer innovative,
high quality products with two top tier distinct brands uniquely
positioned to address key product trends and emerging drivers of
growth in both market segments
- CanniMed and Up Cannabis will
leverage infrastructure and expertise across both platforms to
drive strong synergistic value while focusing on being leaders in
their distinct markets, with best-in-class production and marketing
practices
- Expected to be accretive (before
synergies) on key metrics in 2019
- The Tragically Hip remain intimately
involved as shareholders and active participants in the creation
and support of the Up Cannabis brand
- Significantly improves operational
scale with a targeted 45,000 kg of capacity in 2019 and market
breadth
- Improved capital markets presence
with a pro-forma capitalization exceeding $500mm
- Newstrike shareholders to receive
33.0 CanniMed shares for each 1,000 shares of Newstrike
Conference Call Information
CanniMed and Newstrike will host a conference call and a webcast
accompanied by slides to discuss the recently announced transaction
on Monday, November 20, 2017 at 10:00 AM EST. Analysts, investors
and media are invited and welcome to participate.
Webcast Link:
http://event.on24.com/r.htm?e=1548402&s=1&k=BD174F2AB5EECF4E99B8DEF6666DF687
Conference Call information:
If you are unable to participate in the live webcast, please use
the following call in specifics. The presentation will be available
at www.CanniMedTherapeutics.com.
Toll Free Dial-In: 1-866-521-4909International Dial-In:
647-427-2311Conference ID: 5469669
Archive:
Following completion, an archive version will be available here:
http://event.on24.com/r.htm?e=1548402&s=1&k=BD174F2AB5EECF4E99B8DEF6666DF687.
You can also download the presentation from the CanniMed
Therapeutics website at www.CanniMedTherapeutics.com.
About CanniMed Therapeutics Inc.
CanniMed is a Canadian-based, international plant
biopharmaceutical company and a leader in the Canadian medical
cannabis industry, with 16 years of pharmaceutical cannabis
cultivation experience, state-of-the-art, GMP-compliant production
process and world class research and development platforms with a
wide range of pharmaceutical-grade cannabis products. In addition,
the Company has an active plant biotechnology research and product
development program focused on the production of plant-based
materials for pharmaceutical, agricultural and environmental
applications.
CanniMed, through its subsidiaries, was the first producer to be
licensed under the Marihuana for Medical Purposes Regulations, the
predecessor to the current Access to Cannabis for Medical Purposes
Regulations. It was the sole supplier to Health Canada under the
former medical cannabis system for 13 years, and has been producing
safe and consistent medical cannabis for thousands of Canadian
patients, with no incident of product diversion or recalls.
For more information, please visit our websites: www.cannimed.ca
(patients) and www.cannimedtherapeutics.com (investors).
About Newstrike and Up Cannabis
Newstrike is the parent company of Up Cannabis, a licensed
producer of cannabis that received its cultivation license on
December 19, 2016. Newstrike, together with its strategic partners,
is developing a diverse network of high quality cannabis brands.
For more information visit www.up.ca or www.newstrike.ca.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171120005479/en/
CanniMed Therapeutics Inc.Media:Dara
Willisdhw@cannimed.com416-836-9272orInvestor
Relationsinvest@cannimed.comorUp CannabisMedia:PM
Rendonpm@newstrike.ca416-301-2391orInvestor
RelationsIR@newstrike.ca
Newstrike Resources (TSXV:HIP)
Historical Stock Chart
From Oct 2024 to Nov 2024
Newstrike Resources (TSXV:HIP)
Historical Stock Chart
From Nov 2023 to Nov 2024